Cargando…
High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can
Few antimicrobials are currently active to treat infections caused by extremely resistant Gram-negative bacilli (ERGNB), which represent a serious global public health concern. Tigecycline, which covers the majority of these ERGNB (with the exception of Pseudomonas aeruginosa), is not currently appr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075419/ https://www.ncbi.nlm.nih.gov/pubmed/25043402 http://dx.doi.org/10.1186/cc13942 |